Talk:Priority review
Add topic | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
Content in the lead
[edit]This was stuck in the lead, and is a remarkable claim that X was first, sourced only to the paper about which "first" is claimed. To say "first" we need a third party source saying that. No Wikipedia can say that on their own - that is WP:OR. Moved this here until the "first" claim can be sourced. after that is found, this should go in the body of the article. Unclear if it rises to the importance of being part of the WP:LEAD.
The tropical disease system was first proposed by Duke University faculty David Ridley, Henry Grabowski, and Jeffrey Moe in their 2006 Health Affairs paper: "Developing Drugs for Developing Countries."[1]
References
- ↑ Ridley DB, Grabowski HG, Moe JL (2006). "Developing drugs for developing countries". Health Aff (Millwood). 25 (2): 313–24. doi:10.1377/hlthaff.25.2.313. PMID 16522573.
Wiki Education assignment: Writing in the Sciences
[edit]
This article was the subject of a Wiki Education Foundation-supported course assignment, between 20 January 2026 and 7 May 2026. Further details are available on the course page. Student editor(s): SourceSeeker26 (article contribs).
— Assignment last updated by CSU ENG PROF (talk) 20:56, 24 March 2026 (UTC)
Splitting article
[edit]Priority review is a designation for a drug and a program that allows quicker review by FDA. A priority review voucher/the PRV program in general are separate from the priority review designation/program. This article should be split up into two articles. See priority review and the PRV program. Thebigcheese20 (talk) 01:07, 29 July 2026 (UTC)